{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T10:21:17Z","timestamp":1758190877872,"version":"3.44.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008956","name":"National AIDS Control Organisation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ijtb.2018.06.009","type":"journal-article","created":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T21:49:20Z","timestamp":1531432160000},"page":"129-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacokinetics of rifabutin during atazanavir\/ritonavir co-administration in HIV-infected TB patients"],"prefix":"10.1016","volume":"66","author":[{"given":"Geetha","family":"Ramachandran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.K.","family":"Hemanth Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.K.","family":"Guha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deelip","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Poorana Gangadevi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Rajapandian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijtb.2018.06.009_bib1","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-Infected adults and adolescents","volume":"58","author":"Centres for Disease Control and Prevention","year":"2009","journal-title":"MMWR"},{"key":"10.1016\/j.ijtb.2018.06.009_bib2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1128\/AAC.00724-07","article-title":"Pharmacokinetic interaction between fosamprenavir-ritonavir and rifabutin in healthy subjects","volume":"52","author":"Ford","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijtb.2018.06.009_bib3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/606056","article-title":"Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis","volume":"49","author":"Boulanger","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijtb.2018.06.009_bib4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/AAC.00992-10","article-title":"Pharmacokinetic interaction study of ritonavir-boosted saquinavir in combination with rifabutin in healthy subjects","volume":"55","author":"Zhang","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijtb.2018.06.009_bib5","first-page":"658","article-title":"Uveitis associated with rifabutin therapy","volume":"43","author":"Centres for Disease Control and Prevention","year":"1994","journal-title":"MMWR"},{"key":"10.1016\/j.ijtb.2018.06.009_bib6","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/jac\/dkr266","article-title":"Determination of rifabutin dosing regimen when administered in combination with ritonavir-boosted atazanavir","volume":"66","author":"Zhang","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijtb.2018.06.009_bib7","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1128\/AAC.01749-09","article-title":"Pharmacokinetics of darunavir\/ritonavir and rifabutin co-administered in HIV-negative healthy volunteers","volume":"54","author":"Sekar","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijtb.2018.06.009_bib8","unstructured":"National AIDS Control Organisation. Policies & Guidelines. Available at: naco.gov.in."},{"year":"2016","series-title":"Technical and Operational Guidelines for TB Control in India","author":"Central Tuberculosis Division","key":"10.1016\/j.ijtb.2018.06.009_bib9"},{"key":"10.1016\/j.ijtb.2018.06.009_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3126\/saarctb.v9i2.7975","article-title":"Simple and rapid liquid chromatography method for determination of rifabutin in human plasma","volume":"9","author":"Hemanth Kumar","year":"2013","journal-title":"SAARC J TB, Lung Dis HIV\/AIDS"},{"key":"10.1016\/j.ijtb.2018.06.009_bib11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s40265-014-0222-8","article-title":"Therapeutic drug monitoring in the treatment of tuberculosis: an update","volume":"74","author":"Abdullah","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.ijtb.2018.06.009_bib12","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.5588\/ijtld.13.0390","article-title":"Pharmacokinetics of rifabutin during atazanavir\/ritonavir co-administration in HIV-Infected TB patients in India","volume":"17","author":"Ramachandran","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijtb.2018.06.009_bib13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/jac\/dkp263","article-title":"Pharmacokinetic interactions between rifabutin and lopinavir\/ritonavir in HIV-infected patients with mycobacterial co-infection","volume":"64","author":"Khachi","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.ijtb.2018.06.009_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070611","article-title":"Pharmacokinetics of rifabutin in Japanese HIV-infected patients with or without antiretroviral therapy","volume":"8","author":"Tanuma","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijtb.2018.06.009_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/2050-6511-15-61","article-title":"Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV-infected tuberculosis patients on lopinavir\/ritonavir-based antiretroviral therapy","volume":"5","author":"Naiker","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.ijtb.2018.06.009_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084866","article-title":"Randomised pharmacokinetic trial of rifabutin with lopinavir\/ritonvir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam","volume":"9","author":"Lan","year":"2014","journal-title":"PLoS One"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570718301525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570718301525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:57:23Z","timestamp":1758081443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570718301525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0019570718301525"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2018.06.009","relation":{},"ISSN":["0019-5707"],"issn-type":[{"type":"print","value":"0019-5707"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of rifabutin during atazanavir\/ritonavir co-administration in HIV-infected TB patients","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2018.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}